GovChime
Notice ID: cd23dd97753d48f287272ef81126f357Special Notice

Notice of Intent to Sole Source--POLYSERP�, a Non-FDA Approved Polyvalent F(ab')2 Immunoglobulin Fragments (Equine) Snake Antivenom

Archived. Original response deadline: . Full description on SAM.gov.

Overview

Response deadline
10:00 AM UTC−04:00
Posted
August 4, 2022
Notice type
Special Notice
Agency
Department of WarDepartment of the Army

Notice details

Office
W4PZ USA MED RSCH ACQUIS ACT
Last updated
Sep 9, 2025

Identifiers

Solicitation number
W81XWH22R0083
Notice ID
cd23dd97753d48f287272ef81126f357

Description

The United States Army Medical Research Acquisition Activity (USAMRAA) intends to issue a sole source contract under the authority of FAR 13.106(b)(1) Soliciting from a single source for purchases not exceeding the simplified acquisition threshold and only one source is reasonably available, on or about 19 August 2022 to CRO, LLC, 516 E. Spruce St., Missoula, MT 59802 under NAICS 325414 Biological Product (except Diagnostics) Manufacturing. The US Army Medical Materiel Development Activity (USAMMDA) Force Health Protection (FHP) Directorate has a requirement for: one (1) shipment of Polyvalent F(ab )2 Immunoglobulin Fragments (Equine), Snake Antivenom for multiple African nations. See attachment for details.

Full description on SAM.gov

Award Overview

No prior contract identified

No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.

Contacts

Documents

No documents available.

Lifecycle

Solicitation:W81XWH22R0083
  1. 2×
    Special NoticeCurrentAug 3, 2022

    Notice of Intent to Sole Source--POLYSERP�, a Non-FDA Approved Polyvalent F(ab')2 Immunoglobulin Fragments (Equine) Snake Antivenom

    Notice cd23dd97753d48f287272ef81126f357 on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline

Additional Details

Solicitation Number

W81XWH22R0083

Archive Date

Not specified

Office Address

FORT DETRICK, MD, 21702-5014